Internal Medicine, Hematology & Oncology · Coral Springs, FL
NPI
1265435077
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
3080 NW 99th Ave Fl 2
Coral Springs, FL, 33065
Phone (954) 726-0035
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
146,331 services
Medicare patients, 2024
549
Average age 76
Drug cost, 2024
$9.2M
3,045 prescriptions
Company payments, 2025
$452
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rohan Faria was code Q5110 (injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram), 42,840 times for 16 patients. In total Rohan Faria billed 146,331 services in 106 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 42,840 | 16 | $0.22 | $9,252 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 11,130 | 30 | $5.71 | $64K |
| J0897 Injection, denosumab, 1 mg | Office | 3,900 | 17 | $20.55 | $80K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,600 | 44 | $0.09 | $228 |
| 36415 Venipuncture Blood Collection | Office | 2,247 | 477 | $8.65 | $19K |
| 85025 Blood Count | Office | 2,195 | 472 | $7.61 | $17K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 2,184 | 30 | $0.07 | $159 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,530 | 26 | $0.71 | $1,085 |
| J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | Office | 1,000 | 23 | $1.68 | $1,684 |
| 99213 Office E&M - Established | Office | 756 | 361 | $69.89 | $53K |
| 96372 Injection Administration | Office | 568 | 72 | $11.28 | $6,410 |
| 96375 Injection Administration | Office | 545 | 55 | $12.00 | $6,539 |
| 99214 Office E&M - Established | Office | 523 | 347 | $97.97 | $51K |
| 96413 Chemotherapy Administration | Office | 326 | 56 | $101.28 | $33K |
| 96365 Intravenous Infusion, Hydration | Office | 315 | 71 | $49.06 | $15K |
By year: 2022 $3.1M for 170,752 services; 2023 $3.0M for 171,318 services; 2024 $1.7M for 146,331 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,247 | 477 | $8.65 | $19K |
| 85025 Blood Count | 2,195 | 472 | $7.61 | $17K |
| 80053 Clinical Chemistry | 116 | 95 | $10.35 | $1,201 |
| 82728 Clinical Chemistry | 63 | 54 | $13.36 | $842 |
| 82378 Clinical Chemistry | 63 | 48 | $18.02 | $1,135 |
| 86300 Immunoassay | 26 | 21 | $19.64 | $511 |
| 80048 Clinical Chemistry | 22 | 22 | $8.29 | $182 |
| 82607 Clinical Chemistry | 13 | 12 | $14.78 | $192 |
Medicare prescription drug claims, 2024
In 2024, the drug Rohan Faria prescribed most often to Medicare patients was Letrozole, with 378 prescriptions and refills. In total Rohan Faria wrote 3,045 Medicare prescriptions that cost $9.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 378 | 708 | 83 | $5,913 |
| Prednisone Generic | 179 | 218 | 43 | $1,240 |
| Prochlorperazine Maleate Generic | 144 | 144 | 83 | $1,568 |
| Ondansetron Hcl Generic | 136 | 142 | 88 | $1,459 |
| Anastrozole Generic | 124 | 254 | 27 | $1,298 |
| Eliquis Apixaban | 112 | 148 | 23 | $86K |
| Lactulose Generic | 104 | 114 | 60 | $1,192 |
| Tamoxifen Citrate Generic | 72 | 125 | 18 | $1,620 |
| Calquence Acalabrutinib Maleate | 63 | 63 | Under 11 | $968K |
| Hydroxyurea Generic | 61 | 82 | 11 | $928 |
| Methylprednisolone Generic | 57 | 57 | 26 | $265 |
| Xarelto Rivaroxaban | 52 | 104 | 13 | $57K |
| Folic Acid Generic | 52 | 105 | 13 | $360 |
| Alprazolam Generic | 51 | 51 | 12 | $408 |
| Brukinsa Zanubrutinib | 51 | 51 | Under 11 | $764K |
Brand drugs: - claims; generic drugs: 2,307 claims; opioid claims: 104.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rohan Faria $452 ($452 in general payments such as food, travel and fees) from 9 companies. The largest payer was Janssen Biotech, Inc. with $131.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.